182 related articles for article (PubMed ID: 16547152)
1. SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways.
Gelman IH; Gao L
Mol Cancer Res; 2006 Mar; 4(3):151-8. PubMed ID: 16547152
[TBL] [Abstract][Full Text] [Related]
2. Suppression of chemotaxis by SSeCKS via scaffolding of phosphoinositol phosphates and the recruitment of the Cdc42 GEF, Frabin, to the leading edge.
Ko HK; Guo LW; Su B; Gao L; Gelman IH
PLoS One; 2014; 9(10):e111534. PubMed ID: 25356636
[TBL] [Abstract][Full Text] [Related]
3. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
Lin X; Gelman IH
Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
[TBL] [Abstract][Full Text] [Related]
4. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.
Su B; Bu Y; Engelberg D; Gelman IH
J Biol Chem; 2010 Feb; 285(7):4578-86. PubMed ID: 20018890
[TBL] [Abstract][Full Text] [Related]
5. Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS.
Gelman IH; Lee K; Tombler E; Gordon R; Lin X
Cell Motil Cytoskeleton; 1998; 41(1):1-17. PubMed ID: 9744295
[TBL] [Abstract][Full Text] [Related]
6. Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12.
Su B; Gao L; Meng F; Guo LW; Rothschild J; Gelman IH
Oncogene; 2013 Apr; 32(16):2016-26. PubMed ID: 22710722
[TBL] [Abstract][Full Text] [Related]
7. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
Xia W; Unger P; Miller L; Nelson J; Gelman IH
Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
[TBL] [Abstract][Full Text] [Related]
8. SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis.
Liu Y; Gao L; Gelman IH
BMC Cancer; 2006 Apr; 6():105. PubMed ID: 16638134
[TBL] [Abstract][Full Text] [Related]
9. The guanine nucleotide exchange factor Arhgef5 plays crucial roles in Src-induced podosome formation.
Kuroiwa M; Oneyama C; Nada S; Okada M
J Cell Sci; 2011 May; 124(Pt 10):1726-38. PubMed ID: 21525037
[TBL] [Abstract][Full Text] [Related]
10. Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.
Bu Y; Gao L; Gelman IH
Int J Cancer; 2011 Apr; 128(8):1836-42. PubMed ID: 20568114
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein.
Xia W; Gelman IH
Exp Cell Res; 2002 Jul; 277(2):139-51. PubMed ID: 12083796
[TBL] [Abstract][Full Text] [Related]
12. The SRC substrate Tks5, podosomes (invadopodia), and cancer cell invasion.
Courtneidge SA; Azucena EF; Pass I; Seals DF; Tesfay L
Cold Spring Harb Symp Quant Biol; 2005; 70():167-71. PubMed ID: 16869750
[TBL] [Abstract][Full Text] [Related]
13. SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition.
Su B; Zheng Q; Vaughan MM; Bu Y; Gelman IH
Cancer Res; 2006 Jun; 66(11):5599-607. PubMed ID: 16740695
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase SHP2 suppresses podosome rosette formation in Src-transformed fibroblasts.
Pan YR; Cho KH; Lee HH; Chang ZF; Chen HC
J Cell Sci; 2013 Jan; 126(Pt 2):657-66. PubMed ID: 23178938
[TBL] [Abstract][Full Text] [Related]
15. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells.
Seals DF; Azucena EF; Pass I; Tesfay L; Gordon R; Woodrow M; Resau JH; Courtneidge SA
Cancer Cell; 2005 Feb; 7(2):155-65. PubMed ID: 15710328
[TBL] [Abstract][Full Text] [Related]
16. A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis.
Gelman IH; Tombler E; Vargas J
Histochem J; 2000 Jan; 32(1):13-26. PubMed ID: 10805381
[TBL] [Abstract][Full Text] [Related]
17. IRSp53 mediates podosome formation via VASP in NIH-Src cells.
Oikawa T; Okamura H; Dietrich F; Senju Y; Takenawa T; Suetsugu S
PLoS One; 2013; 8(3):e60528. PubMed ID: 23555988
[TBL] [Abstract][Full Text] [Related]
18. A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo.
Blouw B; Seals DF; Pass I; Diaz B; Courtneidge SA
Eur J Cell Biol; 2008 Sep; 87(8-9):555-67. PubMed ID: 18417249
[TBL] [Abstract][Full Text] [Related]
19. Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.
Guo LW; Gao L; Rothschild J; Su B; Gelman IH
J Biol Chem; 2011 Nov; 286(44):38356-38366. PubMed ID: 21903576
[TBL] [Abstract][Full Text] [Related]
20. A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture.
Lin X; Tombler E; Nelson PJ; Ross M; Gelman IH
J Biol Chem; 1996 Nov; 271(45):28430-8. PubMed ID: 8910468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
